Microglia and schizophrenia: where next?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

8 citing papers in PubMed.

1. Combined Predictors for the Diagnostic Transition from Acute and Transient Psychotic Disorder to Schizophrenia: A Retrospective Study.Neuropsychiatric disease and treatment · 2024
   Article
2. Microglia are necessary for probiotics supplementation to improve impaired fear extinction caused by pregnancy stress in adult offspring of rats.Neurobiology of stress · 2024
   Article
3. Minocycline in Major Depressive Disorder: And overview with considerations on treatment-resistance and comparisons with other psychiatric disorders.Brain, behavior, & immunity - health · 2021
   Article
4. A Genetics Perspective on the Role of the (Neuro)Immune System in Schizophrenia.Schizophrenia research · 2020
   Review
5. Neuropathological correlates and genetic architecture of microglial activation in elderly human brain.Nature communications · 2019
   Article
6. Inflaming sex differences in mood disorders.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019
   Review
7. Gene regulatory mechanisms underlying sex differences in brain development and psychiatric disease.Annals of the New York Academy of Sciences · 2018
   Review
8. Cross Talk: The Microbiota and Neurodevelopmental Disorders.Frontiers in neuroscience · 2017
   Review

Corrections and comments

• Comment on
  In vivo imaging of brain microglial activity in antipsychotic-free and medicated schizophrenia: a [2016
• Comment on
  Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [2017

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as